| Source: |
| Type: |
| HEC1 (also known as HEC1 or NDC80) is a protein that is part of the NDC80 complex, which is crucial for the proper functioning of the mitotic spindle during cell division. It plays a significant role in the attachment of microtubules to kinetochores, ensuring accurate chromosome segregation during mitosis. Dysregulation of HEC1 has been implicated in various cancers, and its expression levels can have prognostic implications. Hec1 is often overexpressed in cancers with poor prognosis. Hec1 is significantly upregulated in cervical cancer tissues and associated with poor prognosis in cervical cancer patients. Its overexpression is associated with various cancers, including breast, lung, ovarian, and colorectal cancers, often correlating with poor prognosis and aggressive tumor behavior. While HEC1 itself is not classified as a traditional oncogene, its dysregulation contributes to oncogenic processes, making it a potential target for therapeutic intervention and a candidate biomarker for cancer prognosis. |
| Prostate Cancer: Alterations in genes such as ERG, SPOP, MYC, androgen receptor (AR), and CHD1, drive PCa progression. TP53 is the most commonly mutated gene in human cancer. HH↑, GLI-1↑, SHH↑ P53↓ The loss of p53 and/or other tumor suppressor genes, reduced capacity for DNA repair, the dysfunction of telomerase activity, and changes in the pathways that govern the growth of cells also mediate the progression of Pca. It has been well documented that Ca2+ influx and MDR1 upregulation are highly associated with GEM metabolism in human pancreatic carcinoma. Increased Growth factor IGF-1/IGF-1R axis activation mediated by both PI3K/Akt or RAF/MEK/ERK system and AR expression remains important in the development and progression of prostate cancer. It has been demonstrated that prostate cancer cells are relatively sensitive to heat stress. Long non-coding RNA MALAT1 has been reported as an oncogenic target in multiple types of cancers, including PC. |
| 76- | QC, | Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy |
| - | in-vitro, | Pca, | PC3 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:22 Cells:% prod#:% Target#:412 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid